Page 2 - Clinical Testing News Today

Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

In this interview, we delve deep into the pioneering world of xenotransplantation and the evolving landscape of gene editing.

LUXEMBOURG, October 24, 2023--Regulatory News: Eurofins Scientific SE (Paris:ERF):

The underrepresentation of women and minorities in research is a long-simmering issue affecting many health problems. Trials without diversity lead to gaps in understanding of how new treatments work for all people.

Next-generation sequencing (NGS) will have a dramatic impact on healthcare in the next decade. But what are the real benefits of this trend? Learn more in this expert panel on accelerating precision medicine with low-cost whole-genome sequencing.

Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The

The first-ever FDA-approved pill for postpartum depression is a landmark achievement, but it could come at a high cost for women in more ways than one.

Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a £2 million ($1.3 million) investment.

COPENHAGEN, Denmark & BOSTON, August 15, 2023--Visiopharm and Boston Cell Standards today announced a partnership to develop a joint technology solution that enables labs to meet key provisions of regulatory changes proposed in a groundbreaking editorial recently published in Archives of Pathology & Laboratory Medicine.

/PRNewswire/ -- Harbinger Health ("Harbinger," "the Company"), a biotechnology company pioneering the detection of early cancer, today announced data...